Viewing Study NCT01311050


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-26 @ 8:48 PM
Study NCT ID: NCT01311050
Status: UNKNOWN
Last Update Posted: 2011-12-13
First Post: 2011-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Sponsor: King Faisal Specialist Hospital & Research Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module